UC teams up with University of Michigan and Eli Lilly to tackle chronic pain

CINCINNATI – Americans are living longer and dealing with more backaches, arthritis and migraines -- but medicine hasn't kept up.

A new team aims to change that. University of Cincinnati, University of Michigan and Eli Lilly researchers will pool their resources as the Midwest Paint Consortium to study new ways to deal with chronic pain of all sorts.

They'll use $400,000 seed money from Lilly, the Indianapolis-based pharmaceutical giant, to first study osteoarthritis – the most common kind that involves pain and swelling from worn down cartilage – and a range of other conditions if their initial work is productive, with the added benefit of creating high-paying jobs for the Tri-State as well as Ann Arbor and Indianapolis.

Dale Edgar, Lilly's global head of Science and Technology Partnerships, hopes the initial research is the beginning of a much more ambitious collaboration among universities and other pharmaceutical companies to find new therapies for the management of chronic pain to meet a pressing need.

"By 2050, 29.7 percent of Americans will be 85 or older," he said. "Pain management will be prominent amongst the issues (for the elderly) unless we come up with better therapies because the solutions that are available for these patients today are really inadequate."

WCPO Insiders can read more about how these experts hope to solve this issue that affects 100 million Americans.

To continue reading: Subscribe Now or